HOXB9 and nonpapillary renal cell carcinoma: Survival analysis indicated that lower expression of HOXA9, HOXA11, and HOXB9 were associated with favorable clinical outcome in ccRCC patients, thus the prognostic prediction performance of HOXA9, HOXA11, and HOXB9 might be controversial with their expression level in ccRCC.